Tailor-made Antibodies
and Tools for Life Science
Home | | | | | Technical Support

Synapsin1 antibody - 106 011BT K.O.

Synapsins are peripheral synaptic vesicle proteins and substrate for several protein kinases
Mouse monoclonal purified IgG
Cat. No.: 106 011BT
Amount: 100 µg
Price: $480.00
Cat. No. 106 011BT 100 µg purified IgG, lyophilized, labeled with Biotin.

Biotin is a small vitamin B complex molecule. Its small size minimizes interference with antibody binding sites and allows for efficient conjugation without compromising antibody functionality.
Biotin conjugated antibodies can be easily detected with Avidin/Streptavidin based secondary detection systems.
The streptavidin-biotin bond is one of the strongest non-covalent biological bonds known.

Albumin and azide were added for stabilization. For reconstitution add 100 µl H2O to get a 1mg/ml solution in PBS. Then aliquot and store at -20°C to -80°C until use.
Antibodies should be stored at +4°C when still lyophilized. Do not freeze!
Applications
 
WB: 1 : 1000 up to 1 : 10000 (AP staining) gallery  
IP: yes (see remarks)
ICC: 1 : 100 up to 1 : 2000 gallery  
IHC: 1 : 500 up to 1 : 10000 gallery  
IHC-P: 1 : 1000 gallery  

Western blot (WB); separation of proteins by PAGE and subsequent transfer to a membrane. Detection of target molecules is carried out with antibodies. Some antibodies require special sample preparation steps. For details, please refer to the “Remarks” section.

Immunoprecipitation (IP); Immunoisolation or pulldown of a target molecule using an antibody. For details and product specific hints, please refer to the ”Remarks” section.

Immunocytochemistry (ICC) on 4% PFA fixed cells. Immunoreactivity is usually revealed by fluorescence. Some antibodies require special fixation methods. For details, please refer to the “Remarks” section.

Immunohistochemistry (IHC) on 4% PFA perfusion fixed tissue with 24h PFA post fixation. Immunoreactivity is usually revealed by fluorescence or a chromogenic substrate. Some antibodies require special fixation methods or antigen retrieval steps. For details, please refer to the ”Remarks” section.

Immunohistochemistry (IHC-P) of formalin fixed, paraffin embedded (FFPE) tissue (some antibodies require special antigen retrieval steps, please refer to the ”Remarks” section). Immunoreactivity is usually revealed by fluorescence or a chromogenic substrate.

Label biotin
Clone 46.1
Subtype IgG1
Immunogen full-length recombinant rat Synapsin1 (UniProt Id: P09951)
Epitop AA 435 to 475 from rat Synapsin1 (UniProt Id: P09951)
Reactivity Reacts with: human (P17600), rat (P09951), mouse (O88935), mammals.
Weaker signal: zebrafish, chicken, other vertebrates.
Other species not tested yet.
Specificity Specific for synapsin 1a and 1b independent of phosphorylation state. K.O. validated
Remarks

IP: Avidin or streptavidin beads are recommended.

Data sheet 106_011bt.pdf

References for Synapsin1 - 106 011BT

Neuronal BIN1 Regulates Presynaptic Neurotransmitter Release and Memory Consolidation.
De Rossi P, Nomura T, Andrew RJ, Masse NY, Sampathkumar V, Musial TF, Sudwarts A, Recupero AJ, Le Metayer T, Hansen MT, Shim HN, et al.
Cell reports (2020) 3010: 3520-3535.e7. 106 011BT ICC, IHC; tested species: mouse
Neuronal BIN1 Regulates Presynaptic Neurotransmitter Release and Memory Consolidation.
De Rossi P, Nomura T, Andrew RJ, Masse NY, Sampathkumar V, Musial TF, Sudwarts A, Recupero AJ, Le Metayer T, Hansen MT, Shim HN, et al.
Cell reports (2020) 3010: 3520-3535.e7. 106 011BT ICC, IHC; tested species: mouse
Cat. No.: 106 011BT
Amount: 100 µg
Price: $480.00
Neuronal BIN1 Regulates Presynaptic Neurotransmitter Release and Memory Consolidation.
De Rossi P, Nomura T, Andrew RJ, Masse NY, Sampathkumar V, Musial TF, Sudwarts A, Recupero AJ, Le Metayer T, Hansen MT, Shim HN, et al.
Cell reports (2020) 3010: 3520-3535.e7. 106 011BT ICC, IHC; tested species: mouse
Neuronal BIN1 Regulates Presynaptic Neurotransmitter Release and Memory Consolidation.
De Rossi P, Nomura T, Andrew RJ, Masse NY, Sampathkumar V, Musial TF, Sudwarts A, Recupero AJ, Le Metayer T, Hansen MT, Shim HN, et al.
Cell reports (2020) 3010: 3520-3535.e7. 106 011BT ICC, IHC; tested species: mouse
Background

Synapsins are neuron-specific phosphoproteins that play a fundamental role in synaptic vesicle trafficking and neurotransmitter release. They are exclusively associated with small synaptic vesicles in presynaptic terminals, with little or no expression in non-neuronal tissues including neuroendocrine cells (1–4). In mammals, three distinct genes—SYN1, SYN2, and SYN3—encode more than eight isoforms through alternative splicing. Synapsin1 is one of the most specific markers of synapses throughout both the central and peripheral nervous systems. In addition to presynaptic terminals, it is localized to sensory nerve endings and peripheral innervation of the gastrointestinal tract, including the small intestine, where it contributes to neurotransmitter release in enteric and extrinsic nerves (2,3). Two splice variants, synapsin1a and synapsin1b, interact with synaptic vesicle membranes and the cytoskeletal proteins actin and spectrin (1). Synapsin2, also expressed in the nervous system, exists in at least two splice variants, whereas synapsin3 displays a more restricted distribution, being enriched in hippocampal neurons and developing neural circuits (4).
Synapsins are major neuronal phosphoproteins and substrates of several kinases, including PKA, CaMK I, and CaMK II, with synapsin1 serving as a reference substrate for calmodulin-dependent protein kinases (1,4). Beyond their established neuronal role, recent studies have implicated synapsins in glioblastoma biology. In particular, synapsin3 has been shown to promote neuronal-like differentiation of glioblastoma stem cells by antagonizing Notch signaling, thereby reducing tumor stemness and progression (5). Moreover, glioblastoma cells can exploit synaptic communication pathways, underscoring a broader role for synaptic proteins in tumor growth and plasticity (6).